Picture of Taisho Pharmaceutical Holdings Co logo

4581 — Taisho Pharmaceutical Holdings Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Taisho Pharmaceutical HD -2017/18 parent results

May 14 (Reuters)- 
          Taisho Pharmaceutical Holdings Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Revenues          7.24            7.13                                 
                 (+1.5 pct)      (-0.8 pct)                              
  Operating         5.68            5.47                                 
                 (+3.8 pct)      (-4.8 pct)                              
  Recurring         5.61            5.41                                 
                 (+3.7 pct)      (-4.7 pct)                              
  Net               5.53            6.86                                 
                 (-19.3 pct)     (+69.4 pct)                             
  EPS             69.20 yen       85.76 yen                              
  EPS Diluted     69.15 yen       85.70 yen                              
  Ann Div        110.00 yen      110.00 yen     110.00 yen               
  -Q2 Div         50.00 yen       50.00 yen      50.00 yen               
  -Q4 Div         60.00 yen       60.00 yen      60.00 yen               
  
  NOTE - Taisho Pharmaceutical Holdings Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4581.T

Recent news on Taisho Pharmaceutical Holdings Co

See all news